
    
      This is prospective randomized trial in high risk urothelial bladder cancer that includes 2
      arms. The randomization will be done by permuted block method to 2 equal comparable groups.
      The total number of subjects will be 50 in each arm (Total=100 subjects).

      This study include patients who may receive neoadjuvant chemotherapy [Gemcitabine+Cisplatin])
      or not.

      Arm (1) in this study (N=50) will received irradiation of both the bladder tumor bed and
      pelvic lymph nodes using IMRT technique. For Arm (2) (N=50) will undergo observation
      following radical cystectomy.
    
  